Litcius/Paper detail

Neuropathological correlates of neuropsychiatric symptoms in dementia

Lucy L. Gibson, Lea T. Grinberg, Dominic ffytche, Renata Elaine Paraízo Leite, Roberta Diehl Rodriguez, Renata Eloah de Lucena Ferretti‐Rebustini, Carlos Augusto Pasqualucci, Ricardo Nitríni, Wilson Jacob Filho, Dag Aarsland, Cláudia Kimie Suemoto

2022Alzheimer s & Dementia47 citationsDOIOpen Access PDF

Abstract

INTRODUCTION: Neuropsychiatric symptoms (NPS) are common in Lewy body disease (LBD), but their etiology is poorly understood. METHODS: In a population-based post mortem study neuropathological data was collected for Lewy body (LB) neuropathology, neurofibrillary tangles (NFT), amyloid beta burden, TDP-43, lacunar infarcts, cerebral amyloid angiopathy (CAA), and hyaline atherosclerosis. Post mortem interviews collected systematic information regarding NPS and cognitive status. A total of 1038 cases were included: no pathology (NP; n = 761), Alzheimer's disease (AD; n = 189), LBD (n = 60), and AD+LBD (n = 28). RESULTS: Hallucinations were associated with higher LB Braak stages, while higher NFT Braak staging was associated with depression, agitation, and greater number of symptoms in the Neuropsychiatric Inventory. Cases with dual AD+LBD pathology had the highest risk of hallucinations, agitation, apathy, and total symptoms but a multiplicative interaction between these pathologies was not significant. DISCUSSION: LB and AD pathology contribute differentially to NPS likely with an additive process contributing to the increased burden of NPS.

Topics & Concepts

NeuropathologyLewy bodyDementiaCerebral amyloid angiopathySenile plaquesDementia with Lewy bodiesApathyPathologyMedicineDepression (economics)PopulationEtiologyAlzheimer's diseasePsychologyDiseaseEnvironmental healthEconomicsMacroeconomicsDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsSchizophrenia research and treatment
Neuropathological correlates of neuropsychiatric symptoms in dementia | Litcius